StonvexLoading…
StonvexStonvexStonvexCore line items from BIAF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.35M | $6.16M | $4.57M | $3.12M |
Operating Income | $-3.62M | $-10.57M | $-7.44M | $-5.14M |
Net Income | $-3.63M | $-14.91M | $-11.77M | $-6.72M |
EPS (Diluted) | $-0.81 | $-8.66 | $-7.55 | $-0.20 |
Total Assets | $7.95M | $10.96M | $11.55M | $4.75M |
Total Liabilities | $4.28M | $3.68M | $2.64M | $6.89M |
Cash & Equivalents | $3.10M | $6.45M | $7.67M | $802.84K |
Free Cash Flow OCF − CapEx | $-3.23M | $-9.39M | $-6.83M | $-4.35M |
Shares Outstanding | 4.50M | 4.50M | 3.47M | 28.46M |